Granahan Investment Management XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 130 filers reported holding XENON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.

Granahan Investment Management ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$8,031
+18.3%
262,705
+20.9%
0.20%
+42.1%
Q4 2021$6,788
+429.9%
217,301
+159.1%
0.14%
+483.3%
Q3 2021$1,281
-17.4%
83,854
+0.7%
0.02%
-17.2%
Q2 2021$1,550
+4.2%
83,249
+0.2%
0.03%
-9.4%
Q1 2021$1,487
-36.9%
83,088
-45.8%
0.03%
-39.6%
Q4 2020$2,358
+34.2%
153,321
-3.4%
0.05%
-11.7%
Q3 2020$1,757
+26.2%
158,704
+43.0%
0.06%
+20.0%
Q2 2020$1,392
+10.6%
110,9990.0%0.05%
-26.5%
Q1 2020$1,259
-10.1%
110,999
+3.9%
0.07%
+6.2%
Q4 2019$1,401
+46.1%
106,839
+0.4%
0.06%
+20.8%
Q3 2019$959
-1.0%
106,459
+8.3%
0.05%
+10.4%
Q2 2019$969
-12.2%
98,259
-9.6%
0.05%
-18.6%
Q1 2019$1,104108,6790.06%